Sort
39,280 grants matching “leukemia”
E2A as a Tumor Suppressor
$398,018Cornelis Murre · University Of California, San Diego · R01 · FY2012 · CA
E2A as a Tumor Suppressor
$398,017Cornelis Murre · University Of California, San Diego · R01 · FY2011 · CA
Formaldehyde Genotoxicity
$397,981Anatoly Zhitkovich · Brown University · R01 · FY2012 · ES
The Novel Role and Mechanism of RBM33 in Leukemogenesis
$397,927Zhijian Qian · University Of Florida · R01 · FY2023 · CA
E2A AS A POTENTIAL TUMOR SUPPRESSOR
$397,839University Of California San Diego · R01 · FY2003 · CA
Targeting ER stress response in B-cell chronic lymphocytic leukemia
$397,822Chih-Chi Andrew Hu · Methodist Hospital Research Institute · R01 · FY2023 · CA
MLL Family Histone Methyltransferases in Myeloid Leukemia
$397,815Patricia A Ernst · University Of Colorado Denver · R01 · FY2019 · CA
Mechanism(s) of TAL1- and NOTCH1-mediated Leukemogenesis
$397,813Michelle Alice Kelliher · Univ Of Massachusetts Med Sch Worcester · R01 · FY2025 · CA
Targeted activation of autoimmune checkpoints in B cell malignancies
$397,813Markus Mãschen · Yale University · R01 · FY2021 · CA
Mechanism(s) of TAL1- and NOTCH1-mediated Leukemogenesis
$397,813Michelle Alice Kelliher · Univ Of Massachusetts Med Sch Worcester · R01 · FY2023 · CA
Mechanism(s) of TAL1- and NOTCH1-mediated Leukemogenesis
$397,813Michelle Alice Kelliher · Univ Of Massachusetts Med Sch Worcester · R01 · FY2022 · CA
Molecular Mechanisms of Adverse Metabolic Events by Asparaginase.
$397,803Tracy G. Anthony · Rutgers, The State Univ Of N.J. · R01 · FY2012 · HD
Toxicity Monitoring on Phase III Trials with Administrative Data
$397,781Richard Aplenc · Children'S Hosp Of Philadelphia · R01 · FY2014 · CA
The Fanconi anemia pathway: role in DNA interstrand cross-link repair
$397,738Johannes Walter · Harvard Medical School · R01 · FY2013 · HL
Characterization of Erythropoiesis and Erythroid Cells.
$397,720Jeffery Miller · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2009 · DK
The Role of Pacs1-Wdr37 inLymphocyte Quiescence and Survival
$397,700Evan Nair-Gill · Ut Southwestern Medical Center · R01 · FY2025 · AI
Fanconi Anemia stem cells allow molecular characterization of acute leukemia
$397,686David W. Clapp · Indiana University Indianapolis · R01 · FY2008 · CA
Cooperating genes in inv (16) acute myeloid leukemia
$397,657Lucio H. Castilla · Univ Of Massachusetts Med Sch Worcester · R01 · FY2009 · CA
Antiretroviral Activity of TRIM5alpha
$397,645Joseph G Sodroski · Dana-Farber Cancer Inst · R01 · FY2008 · AI
Antiretroviral Activity of TRIM5alpha
$397,645Joseph G Sodroski · Dana-Farber Cancer Inst · R01 · FY2009 · AI
Mechanisms of immune evasion in T-cell acute lymphoblastic leukemia and its therapeutic implications
$397,633Birgit Knoechel · Dana-Farber Cancer Inst · R01 · FY2023 · CA
Biology of Alpha Particle Immunotherapy
$397,626David A Scheinberg · Sloan-Kettering Inst Can Research · R01 · FY2013 · CA
MINORITY BASED COMMUNITY CLINICAL ONCOLOGY PROGRAM
$397,626Mobile Infirmary Medical Center · U10 · FY2001 · CA
Generalizable Nanosensors for Probing Highly Specific Interactions of Protein Kinases
$397,599Liviu Movileanu · Syracuse University · R01 · FY2025 · GM
Generalizable Nanosensors for Probing Highly Specific Interactions of Protein Kinases
$397,590Liviu Movileanu · Syracuse University · R01 · FY2024 · GM